|
|
1)
|
chain |
C |
residue |
50 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
2)
|
chain |
C |
residue |
53 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
3)
|
chain |
C |
residue |
55 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
4)
|
chain |
C |
residue |
56 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
5)
|
chain |
C |
residue |
60 |
type |
|
sequence |
I
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
6)
|
chain |
C |
residue |
61 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
7)
|
chain |
C |
residue |
62 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
8)
|
chain |
C |
residue |
63 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
9)
|
chain |
C |
residue |
101 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
10)
|
chain |
C |
residue |
102 |
type |
|
sequence |
K
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
11)
|
chain |
C |
residue |
104 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC5
|
|
12)
|
chain |
C |
residue |
50 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
13)
|
chain |
C |
residue |
53 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
14)
|
chain |
C |
residue |
55 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
15)
|
chain |
C |
residue |
56 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
16)
|
chain |
C |
residue |
60 |
type |
|
sequence |
I
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
17)
|
chain |
C |
residue |
61 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
18)
|
chain |
C |
residue |
62 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
19)
|
chain |
C |
residue |
63 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
20)
|
chain |
C |
residue |
101 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
21)
|
chain |
C |
residue |
102 |
type |
|
sequence |
K
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
22)
|
chain |
C |
residue |
104 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and HIS C 54
|
source |
: AC6
|
|
23)
|
chain |
C |
residue |
33 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
24)
|
chain |
C |
residue |
34 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
25)
|
chain |
C |
residue |
35 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
26)
|
chain |
C |
residue |
37 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
27)
|
chain |
C |
residue |
54 |
type |
|
sequence |
H
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
28)
|
chain |
C |
residue |
55 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
29)
|
chain |
C |
residue |
61 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
30)
|
chain |
C |
residue |
62 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
31)
|
chain |
C |
residue |
63 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
32)
|
chain |
C |
residue |
101 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
33)
|
chain |
C |
residue |
102 |
type |
|
sequence |
K
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
34)
|
chain |
C |
residue |
104 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
35)
|
chain |
C |
residue |
116 |
type |
|
sequence |
T
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
36)
|
chain |
C |
residue |
117 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC7
|
|
37)
|
chain |
C |
residue |
33 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
38)
|
chain |
C |
residue |
34 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
39)
|
chain |
C |
residue |
35 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
40)
|
chain |
C |
residue |
37 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
41)
|
chain |
C |
residue |
54 |
type |
|
sequence |
H
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
42)
|
chain |
C |
residue |
55 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
43)
|
chain |
C |
residue |
61 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
44)
|
chain |
C |
residue |
62 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
45)
|
chain |
C |
residue |
63 |
type |
|
sequence |
G
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
46)
|
chain |
C |
residue |
101 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
47)
|
chain |
C |
residue |
102 |
type |
|
sequence |
K
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
48)
|
chain |
C |
residue |
104 |
type |
|
sequence |
P
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
49)
|
chain |
C |
residue |
116 |
type |
|
sequence |
T
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
50)
|
chain |
C |
residue |
117 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN C 400 and SER L 36
|
source |
: AC8
|
|
51)
|
chain |
C |
residue |
19 |
type |
|
sequence |
H
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AC9
|
|
52)
|
chain |
C |
residue |
68 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AC9
|
|
53)
|
chain |
C |
residue |
91 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AC9
|
|
54)
|
chain |
C |
residue |
92 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AC9
|
|
55)
|
chain |
C |
residue |
93 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AC9
|
|
56)
|
chain |
C |
residue |
19 |
type |
|
sequence |
H
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AD1
|
|
57)
|
chain |
C |
residue |
68 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AD1
|
|
58)
|
chain |
C |
residue |
91 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AD1
|
|
59)
|
chain |
C |
residue |
92 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AD1
|
|
60)
|
chain |
C |
residue |
93 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN D 400 and SER H 36
|
source |
: AD1
|
|
61)
|
chain |
C |
residue |
19 |
type |
|
sequence |
H
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD2
|
|
62)
|
chain |
C |
residue |
23 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD2
|
|
63)
|
chain |
C |
residue |
68 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD2
|
|
64)
|
chain |
C |
residue |
91 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD2
|
|
65)
|
chain |
C |
residue |
92 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD2
|
|
66)
|
chain |
C |
residue |
93 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD2
|
|
67)
|
chain |
C |
residue |
19 |
type |
|
sequence |
H
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD3
|
|
68)
|
chain |
C |
residue |
23 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD3
|
|
69)
|
chain |
C |
residue |
68 |
type |
|
sequence |
E
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD3
|
|
70)
|
chain |
C |
residue |
91 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD3
|
|
71)
|
chain |
C |
residue |
92 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD3
|
|
72)
|
chain |
C |
residue |
93 |
type |
|
sequence |
F
|
description |
binding site for Di-peptide XLN D 400 and HIS D 54
|
source |
: AD3
|
|